BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Gatehouse Bio

Gatehouse Bio’s ‘sRNAlytics platform’ identifies novel small RNA (sRNA) signatures and illuminates molecular pathways correlated to and potentially driving disease. “Our annotation library of over 1.4M small RNA features coupled with our biology-directed machine learning algorithms enable us to see signal where others have only seen noise,” said Dr. David W. Salzman, CEO and Chief Scientist, Gatehouse Bio.

Become a Member to view additional information about this company

Posts Mentioning This Company